jubilant life sciences
Jump to
453 Results Found
  • Jubilant Life share at 52-week high as Rakesh Jhunjhunwala raises stake Jun 16, 2020 12:44 PM IST

    Jubilant Life share at 52-week high as Rakesh Jhunjhunwala raises stake

    Rakesh Radheshyam Jhunjhunwala held 4.41 percent stake (or 70.25 lakh equity shares) in the pharma company as per March shareholding pattern available on exchanges.

  • Buy Jubilant Life Sciences; target of Rs 867: Anand Rathi Jun 14, 2020 03:51 PM IST

    Buy Jubilant Life Sciences; target of Rs 867: Anand Rathi

    Anand Rathi is bullish on Jubilant Life Sciences has recommended buy rating on the stock with a target price of Rs 867 in its research report dated June 12, 2020.

  • Hold Jubilant Life Sciences; target of Rs 414: Prabhudas Lilladher Jun 02, 2020 11:30 AM IST

    Hold Jubilant Life Sciences; target of Rs 414: Prabhudas Lilladher

    Prabhudas Lilladher recommended Hold rating on Jubilant Life Sciences with a target price of Rs 414 in its research report dated Jun 01, 2020.

  • Jubilant Life Consolidated March 2020 Net Sales at Rs 2,391.41 crore, up 0.24% Y-o-Y Jun 02, 2020 09:31 AM IST

    Jubilant Life Consolidated March 2020 Net Sales at Rs 2,391.41 crore, up 0.24% Y-o-Y

  • Jubilant Life Standalone March 2020 Net Sales at Rs 791.36 crore, down 8.53% Y-o-Y Jun 02, 2020 09:31 AM IST

    Jubilant Life Standalone March 2020 Net Sales at Rs 791.36 crore, down 8.53% Y-o-Y

  • Buy Jubilant Life Sciences; target of Rs 550: ICICI Direct Jun 02, 2020 08:46 AM IST

    Buy Jubilant Life Sciences; target of Rs 550: ICICI Direct

    ICICI Direct is bullish on Jubilant Life Sciences has recommended buy rating on the stock with a target price of Rs 550 in its research report dated Jun 01, 2020.

  • Buy Jubilant Life Sciences; target of Rs 515: Motilal Oswal Jun 01, 2020 03:21 PM IST

    Buy Jubilant Life Sciences; target of Rs 515: Motilal Oswal

    Motilal Oswal is bullish on Jubilant Life Sciences has recommended buy rating on the stock with a target price of Rs 515 in its research report dated May 30, 2020.

  • Jubilant Life Sciences posts Rs 260.49 crore profit for March quarter May 29, 2020 08:39 PM IST

    Jubilant Life Sciences posts Rs 260.49 crore profit for March quarter

    Consolidated revenue from operations stood at Rs 2,391.41 crore for the quarter under consideration as against Rs 2,385.58 crore for the same period year ago, it added.

  • Jubilant Life Sciences signs agreement with Gilead for remdesivir May 12, 2020 09:10 PM IST

    Jubilant Life Sciences signs agreement with Gilead for remdesivir

    Under the licencing agreement, the company has the right to receive technology transfer of the Gilead manufacturing process to scale up production.

  • Jubilant Life jumps 5% as Rakesh Jhunjhunwala raises stake to 4.41% in March quarter Apr 21, 2020 01:14 PM IST

    Jubilant Life jumps 5% as Rakesh Jhunjhunwala raises stake to 4.41% in March quarter

    In December quarter, he held 3.45 percent stake in the company, which meant the shareholding increased by 0.96 percent during the March quarter.

  • Jubilant Life Standalone December 2019 Net Sales at Rs 801.18 crore, down 6.79% Y-o-Y Feb 04, 2020 09:29 AM IST

    Jubilant Life Standalone December 2019 Net Sales at Rs 801.18 crore, down 6.79% Y-o-Y

  • Jubilant Life Consolidated December 2019 Net Sales at Rs 2,315.21 crore, down 2.6% Y-o-Y Feb 04, 2020 09:22 AM IST

    Jubilant Life Consolidated December 2019 Net Sales at Rs 2,315.21 crore, down 2.6% Y-o-Y

  • Jubilant Life Sciences Q3 net profit down 24% to Rs 203.38cr Jan 31, 2020 05:00 PM IST

    Jubilant Life Sciences Q3 net profit down 24% to Rs 203.38cr

    Net sales during the quarter under review stood at Rs 2,279.89 crore, down 3.11 per cent, as against Rs 2,353.08 crore in the corresponding period a year ago.

  • Promoter sells Rs 57 crore worth shares of Jubilant Life Sciences Nov 18, 2019 08:42 PM IST

    Promoter sells Rs 57 crore worth shares of Jubilant Life Sciences

    Promoter entity sold shares at a price of Rs 493 per share, as per bulk deals data available on the BSE website.

  • Rakesh Jhunjhunwala's Rare Enterprises buys 1% stake in Jubilant Life Jul 30, 2019 08:13 PM IST

    Rakesh Jhunjhunwala's Rare Enterprises buys 1% stake in Jubilant Life

    Rakesh Radheshyam Jhunjhunwala already held 1.90 percent stake in Jubilant as per shareholding pattern of June 2019.

  • Buy Jubilant Life Sciences; target of Rs 845: HDFC Securities Jul 29, 2019 05:19 PM IST

    Buy Jubilant Life Sciences; target of Rs 845: HDFC Securities

    HDFC Securities is bullish on Jubilant Life Sciences has recommended buy rating on the stock with a target price of Rs 845 in its research report dated July 29, 2019.

  • Jubilant Life Sciences Q1 net profit slips 7.68% to Rs 185 cr Jul 26, 2019 05:45 PM IST

    Jubilant Life Sciences Q1 net profit slips 7.68% to Rs 185 cr

    Consolidated total revenue from operations, however, rose to Rs 2,181.86 crore for the quarter under consideration as against Rs 2,078.65 crore in the same period a year ago.

  • Jubilant Life Consolidated June 2019 Net Sales at Rs 2,181.86 crore, up 4.97% Y-o-Y Jul 26, 2019 03:31 PM IST

    Jubilant Life Consolidated June 2019 Net Sales at Rs 2,181.86 crore, up 4.97% Y-o-Y

  • Jubilant Life Standalone June 2019 Net Sales at Rs 789.82 crore, down 4.45% Y-o-Y Jul 26, 2019 03:31 PM IST

    Jubilant Life Standalone June 2019 Net Sales at Rs 789.82 crore, down 4.45% Y-o-Y

  • Jubilant Life Sciences Q1 PAT may dip 10.4% YoY to Rs. 181.4 cr: Prabhudas Lilladher Jul 12, 2019 05:12 PM IST

    Jubilant Life Sciences Q1 PAT may dip 10.4% YoY to Rs. 181.4 cr: Prabhudas Lilladher

    Net Sales are expected to increase by 13 percent Y-o-Y (down 1.6 percent Q-o-Q) to Rs. 2,348.5 crore, according to Prabhudas Lilladher.

  • Troubles brew at this pharmacy but analysts see up to 100% return in a year Jul 03, 2019 10:26 AM IST

    Troubles brew at this pharmacy but analysts see up to 100% return in a year

    Jubilant Life's performance would be driven by market share gains in key radiopharmaceutical products, a ramp-up in CMO business, capacity additions in finished dosages & Life Science Chemical segment and opportunities from the supply of ethanol to government, IDBI Capital said

  • Buy Jubilant Life Sciences; target of Rs 800: Motilal Oswal Jun 11, 2019 04:36 PM IST

    Buy Jubilant Life Sciences; target of Rs 800: Motilal Oswal

    Motilal Oswal is bullish on Jubilant Life Sciences has recommended buy rating on the stock with a target price of Rs 800 in its research report dated May 18, 2019.

  • Buy Jubilant Life Sciences; target of Rs 915: HDFC Securities Jun 04, 2019 03:52 PM IST

    Buy Jubilant Life Sciences; target of Rs 915: HDFC Securities

    HDFC Securities is bullish on Jubilant Life Sciences has recommended buy rating on the stock with a target price of Rs 915 in its research report dated May 19, 2019.

  • Buy Jubilant Life Sciences; target of Rs 710: ICICI Direct May 29, 2019 10:02 PM IST

    Buy Jubilant Life Sciences; target of Rs 710: ICICI Direct

    ICICI Direct recommended is bullish on Jubilant Life Sciences has recommended buy rating on the stock with a target price of Rs 710 in its research report dated May 20, 2019.

  • Buy Jubilant Life Sciences; target of Rs 750: Dolat Capital May 23, 2019 11:12 PM IST

    Buy Jubilant Life Sciences; target of Rs 750: Dolat Capital

    Dolat Capital is bullish on Jubilant Life Sciences has recommended Buy rating on the stock with a target price of Rs 750 in its research report dated May 21, 2019.

Sections